<DOC>
	<DOC>NCT00730977</DOC>
	<brief_summary>A novel dry powder inhaler device will be used to administer mannitol to healthy subjects and subjects with bronchiectasis in single doses higher than previously given.The main objective is to assess tolerability of these doses using the new device.</brief_summary>
	<brief_title>A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device</brief_title>
	<detailed_description />
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>healthy or bronchiectatic; 18 years and over uncontrolled asthma, unstable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>